Glaxo investors threatened
Investors in GlaxoSmithKline have been sent intimidating letters by animal rights activists who have warned them to sell their shares.
GSK said many of its investors had been warned to sell their shares within a fortnight, or their details would be posted on an animal rights group’s website.
The threats came from the Campaign Against Huntingdon Life Sciences, who have targeted GSK as a business partner of the animal testing firm, Huntingdon Life Sciences.
Yet GSK insisted it would continue to work with Huntingdon despite the threats. And it advised any of its shareholders that had received a letter to report the matter to the police.
It also told investors that wanted to protect their privacy to transfer their shares to the GSK corporate nominee service.
In a statement the firm said: “We are very concerned that individuals have been targeted in this way, and condemn the group responsible.”